Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Metlife Inc (MET)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 46,102,400
  • Shares Outstanding, K 950,369
  • Annual Sales, $ 67,941 M
  • Annual Income, $ 5,123 M
  • 60-Month Beta 1.11
  • Price/Sales 0.68
  • Price/Cash Flow 9.43
  • Price/Book 0.78

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 1.34
  • Number of Estimates 6
  • High Estimate 1.38
  • Low Estimate 1.28
  • Prior Year 1.30
  • Growth Rate Est. (year over year) +3.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.70 +6.81%
on 06/03/19
50.40 -3.15%
on 05/21/19
+1.31 (+2.76%)
since 05/14/19
3-Month
41.41 +17.87%
on 03/22/19
50.40 -3.15%
on 05/21/19
+3.97 (+8.85%)
since 03/14/19
52-Week
37.76 +29.26%
on 12/26/18
50.40 -3.15%
on 05/21/19
+2.04 (+4.36%)
since 06/14/18

Most Recent Stories

More News
Top Ranked Income Stocks to Buy for June 14th

Top Ranked Income Stocks to Buy for June 14th

PUK : 40.76 (-1.66%)
FAF : 52.99 (+0.26%)
MET : 48.81 (+0.62%)
LBAI : 15.79 (+0.38%)
Endor Wins MetLife Korea's Innovation Program, Collab 5.0

MetLife Korea today announced Endor as the winner of its open innovation program, collab 5.0. The Israel-based startup has won a USD 100,000 contract to pilot their solution with the...

MET : 48.81 (+0.62%)
MetLife Announces Date for Investor Conference

MetLife, Inc. (NYSE: MET) today announced it will host an investor conference on Thursday, December 12, 2019 in New York. Presenters will include members of MetLife's senior management team....

MET : 48.81 (+0.62%)
MGIC Investment's (MTG) May Insurance in Force Impressive

MGIC Investment's (MTG) insurance in force was $213.3 billion, up 7% year over year.

MTG : 13.83 (-0.14%)
RDN : 23.29 (+1.79%)
MET : 48.81 (+0.62%)
AIG : 53.31 (+0.21%)
MET or AIG: Which Multi-Line Insurer Looks More Attractive?

Here we take a look at whether MET or AIG is better poised in the multi-line insurance industry, which is benefiting from rate increase, business diversification and product innovation.

PRU : 99.23 (-0.10%)
WRB : 65.62 (+1.16%)
MET : 48.81 (+0.62%)
AIG : 53.31 (+0.21%)
Should Value Investors Consider MetLife (MET) Stock Now?

Let's see if MetLife, Inc. (MET) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

MET : 48.81 (+0.62%)
Why MetLife (MET) Could Be a Top Value Stock Pick

MetLife (MET) seems to be a good value pick, as it has impressive value metrics, and is seeing solid earnings estimate revisions as well.

MET : 48.81 (+0.62%)
Metlife 'Speed Dates' 16 Cutting-Edge Insurtech Start-Ups in 8-Hour Innovation Hunt

On Thursday, June 6, MetLife will host its fifth "Ignition" summit, an annual one-day experience to identify emerging digital capabilities that will drive transformation in the insurance...

MET : 48.81 (+0.62%)
MetLife (MET) is a Top Dividend Stock Right Now: Should You Buy?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.

MET : 48.81 (+0.62%)
MetLife (MET) Down 0.1% Since Last Earnings Report: Can It Rebound?

MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MET : 48.81 (+0.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade MET with:

Business Summary

MetLife, Inc. is a leading global provider of insurance, annuities and employee benefit programs, serving 90 million customers. Through its subsidiaries and affiliates, MetLife holds leading market positions in the United States, Japan, Latin America, Asia, Europe, the Middle East and Africa. MetLife...

See More

Key Turning Points

2nd Resistance Point 49.40
1st Resistance Point 49.10
Last Price 48.81
1st Support Level 48.39
2nd Support Level 47.98

See More

52-Week High 50.40
Last Price 48.81
Fibonacci 61.8% 45.57
Fibonacci 50% 44.08
Fibonacci 38.2% 42.59
52-Week Low 37.76

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar